60
Participants
Start Date
April 30, 2002
Primary Completion Date
July 31, 2003
Study Completion Date
July 31, 2003
natalizumab
Long Island Clinical Research Associates, LLP, Great Neck
Gastroenterology Consultants, Virginia Beach
Internal Medicine Associates, Danville
Wake Research Associates, Raleigh
Boice-Willis Clinic, Rocky Mount
Asheville Gastroenterology, Asheville
Columbia Gastroenterology Associates, Columbia
Atlanta Gastroenterology Associates, Atlanta
Borland Groover Clinic, Jacksonville
Digestive Disease Associates, Gainesville
Gastroenterology Center of the MidSouth, Memphis
Memphis Gastroenterology Group, Memphis
University of Kentucky Medical Center, Lexington
Mercury Street Medical, Butte
Austin Gastroenterology, Austin
Virginia Mason Medical Center, Seattle
Digestive Health Specialists, Tacoma
Massachusetts General Hospital, Boston
Lead Sponsor
Collaborators (1)
Elan Pharmaceuticals
INDUSTRY
Biogen
INDUSTRY